Mechanisms of Leucocyte Migration Inhibition by Breast Tumour Cell Fractions

Overview

Journal Br J Cancer

Specialty Oncology

Date 1976 Jul 1

PMID 952712

Authors

B M Jones

Affiliations

Soon will be listed here.

Abstract

Leucocyte migration inhibition by autologous breast tumour cell fractions was mediated by a soluble factor synthesized and released by mononuclear leucocytes and active against migrating granulocytes. This mechanism is similar to that previously described in respect to cell-mediated sensitivity to microbial antigens. Alternative mechanisms involving directly reactive granulocytes or cytophilic antibodies were rarely operative in the migration tests.

References

Jones B, Turnbull A . Horizontal studies of cell mediated immune reactions to autologous tumour antigens in patients with operable mammary carcinoma. Br J Cancer. 1975; 32(3):339-44. PMC: 2024748. DOI: 10.1038/bjc.1975.232. View

Fimmel P . Studies on leukocyte migration inhibiton: the role of E rosette-forming cells in specific antigen-induced inhibition of migration. J Immunol. 1975; 115(1):135-8. View

SEGALL A, Weiler O, Genin J, Lacour J, Lacour F . In vitro study of cellular immunity against autochthonous human cancer. Int J Cancer. 1972; 9(2):417-25. DOI: 10.1002/ijc.2910090221. View

Cochran A, Jehn U, GOTHOSKAR B . Cell-mediated immunity in malignant melanoma. Lancet. 1972; 1(7764):1340-1. DOI: 10.1016/s0140-6736(72)91070-7. View

WOLBERG W . Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers. Cancer Res. 1971; 31(6):798-802. View

Rocklin R, Macdermott R, Chess L, Schlossman S, David J . Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974; 140(5):1303-16. PMC: 2139736. DOI: 10.1084/jem.140.5.1303. View

Epstein L, Kreth H, Herzenberg L . Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol. 1974; 12(3):407-21. DOI: 10.1016/0008-8749(74)90097-5. View

Senyk G, Hadley W . In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test. Infect Immun. 1973; 8(3):370-80. PMC: 422858. DOI: 10.1128/iai.8.3.370-380.1973. View

Rocklin R . Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol. 1974; 112(4):1461-6. View

10.

Kjaer M . In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma. Eur J Cancer (1965). 1974; 10(8):523-31. DOI: 10.1016/0014-2964(74)90077-2. View

11.

Jones B, Turnbull A . In vitro cellular immunity in mammary carcinoma. Br J Cancer. 1974; 29(4):337-9. PMC: 2009176. DOI: 10.1038/bjc.1974.76. View

12.

McCOY J, Jerome L, Dean J, CANNON G, ALFORD T, Doering T . Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma. J Natl Cancer Inst. 1974; 53(1):11-7. DOI: 10.1093/jnci/53.1.11. View

13.

CLAUSEN J . Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay. J Immunol. 1973; 110(2):546-51. View

14.

Soborg M . Interaction of human peripheral lymphocytes and granulocytes in the migration-inhibition reaction. Acta Med Scand. 1969; 185(3):221-6. View

15.

Packalen T, Wasserman J . Inhibition of migration of normal guinea pig blood leukocytes by homologous immune gamma 2-globulin in the presence of specific antigen. Int Arch Allergy Appl Immunol. 1971; 41(5):790-6. DOI: 10.1159/000230569. View

16.

Jones B, Connolly C, Isaacson P, Turner D, Turnbull A . Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations. Br J Cancer. 1976; 34(1):94-6. PMC: 2025140. DOI: 10.1038/bjc.1976.128. View

17.

McCOY J, Jerome L, Dean J, Perlin E, Oldham R, Char D . Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst. 1975; 55(1):19-23. DOI: 10.1093/jnci/55.1.19. View

18.

Ellis R, Wernick G, Zabriskie J, GOLDMAN L . Immunologic competence of regional lymph nodes in patients with breast cancer. Cancer. 1975; 35(3):655-9. DOI: 10.1002/1097-0142(197503)35:3<655::aid-cncr2820350318>3.0.co;2-m. View

19.

Andersen V, BJERRUM O, BENDIXEN G, Schiodt T, DISSING I . Effect of autologous mammary tumour extracts on human leukocyte migration in vitro. Int J Cancer. 1970; 5(3):357-63. DOI: 10.1002/ijc.2910050308. View

20.

Amos H, GURNER B, Olds R, Coombs R . Passive sensitization of tissue cells. II. Ability of cytophilic antibody to render the migration of guinea pig peritoneal exudate cells inhibitable by antigen. Int Arch Allergy Appl Immunol. 1967; 32(5):496-505. View